Pantoprazole Export Market Intelligence: India's 744 Suppliers Shipping to 154 Countries — TransData Nexus 2026

Q: Who are the top pantoprazole exporters from India?

The top pantoprazole exporters from India are: 1. MYLAN LABORATORIES LIMITED — $926.3M (69.2% market share); 2. AUROBINDO PHARMA LTD — $167.6M (12.5% market share); 3. EUGIA PHARMA SPECIALITIES LIMITED — $32.4M (2.4% market share); 4. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $31.0M (2.3% market share); 5. TORRENT PHARMACEUTICALS LTD — $19.7M (1.5% market share). Together they account for 87.9% of India's total pantoprazole export value.

Q: What is the total export value of pantoprazole from India?

The total export value of pantoprazole from India is $1.3B USD, recorded across 11,610 shipment transactions from 744 active exporters to 154 destination countries. The average shipment value is $115.3K.

Q: Which countries import pantoprazole from India?

India exports pantoprazole to 154 countries worldwide. The top importing countries are: UNITED STATES (68.3% share, $914.6M), MALTA (12.6% share, $169.1M), CANADA (6.3% share, $84.3M), BELGIUM (1.3% share, $17.7M), TANZANIA (1.2% share, $16.5M). These five markets account for 89.8% of total export value.

Q: What is the HS code for pantoprazole exports from India?

The primary HS code for pantoprazole exports from India is 30049039. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of pantoprazole exports from India?

The average unit price for pantoprazole exports from India is $3.77 USD per unit, with prices ranging from $0.00 to $4449.94 depending on formulation, packaging, and order volume. The total market is valued at $1.3B across 11,610 shipments.

Q: Which ports handle pantoprazole exports from India?

The primary ports for pantoprazole exports from India are NHAVA SHEVA SEA (INNSA1) (9.3% of shipments), SAHAR AIR (8.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.1% of shipments), JNPT/ NHAVA SHEVA SEA (5.6% of shipments), JNPT (4.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of pantoprazole?

India is one of the world's leading exporters of pantoprazole due to its large base of 744 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports pantoprazole to 154 countries, demonstrating 79% global market coverage.

Q: What certifications do Indian pantoprazole exporters need?

Indian pantoprazole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import pantoprazole from India?

There are 1,893 registered buyers importing pantoprazole from India, spread across 154 countries. The repeat buyer rate is 61.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top pantoprazole supplier from India?

MYLAN LABORATORIES LIMITED is the leading pantoprazole exporter from India with a market share of 69.2% and total export value of $926.3M across 661 shipments. The top 5 suppliers together control 87.9% of total export value.

Suresh Sormare

Pantoprazole

India Pharmaceutical Trade Intelligence

$1.3B744 Suppliers154 CountriesHS 30049039

ExportsIndia → UNITED STATES68.3%India → MALTA12.6%

ImportsGERMANY → India$152.4K BRAZIL → India$68.7K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Pantoprazole Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Pantoprazole to the World

Between 2022 and 2026, India exported $1.3B worth of pantoprazole across 11,610 verified shipments to 154 countries — covering 79% of world markets in the Gastrointestinal segment. The largest destination is UNITED STATES (68.3%). MYLAN LABORATORIES LIMITED leads with a 69.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·

Pantoprazole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Pantoprazole export data snapshot — $1.3B · 744 exporters · 154 countriesTransData Nexus · Indian Customs Data

Top Pantoprazole Exporters from India

744 active exporters · Ranked by export value

View all 744 →

Top Pantoprazole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MYLAN LABORATORIES LIMITED	$926.3M	661	10	69.2%
2	AUROBINDO PHARMA LTD

Top Countries Importing Pantoprazole from India

154 destination markets · Ranked by import value

All 154 countries →

Top Countries Importing Pantoprazole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$914.6M	68.3%
2	MALTA	$169.1M	12.6%
3	CANADA	$84.3M	6.3%
4	BELGIUM	$17.7M	1.3%
5	TANZANIA	$16.5M	1.2%
6	SOUTH AFRICA	$13.3M	1.0%
7	YEMEN	$10.3M	0.8%
8	HUNGARY	$9.2M	0.7%
9	AUSTRALIA	$8.1M	0.6%
10	FRANCE	$7.0M	0.5%

UNITED STATES is India's largest pantoprazole export destination, absorbing 68.3% of total exports worth $914.6M. The top 5 importing countries — UNITED STATES, MALTA, CANADA, BELGIUM, TANZANIA — together account for 89.8% of India's total pantoprazole export value. The remaining 149 destination countries collectively receive the other 10.2%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Pantoprazole to India?

25 origin countries · Total import value: $680.2K

India imports pantoprazole from 25 countries with a combined import value of $680.2K. The largest supplier is UNITED ARAB EMIRATES ($182.1K, 30 shipments), followed by UNITED STATES and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Pantoprazole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED ARAB EMIRATES	$182.1K	30	26.8%
2	UNITED STATES	$176.0K	43	25.9%
3	GERMANY	$152.4K	32	22.4%
4	BRAZIL	$68.7K	11	10.1%
5	FRANCE	$34.8K	2	5.1%
6	UNITED KINGDOM	$18.1K	11	2.7%
7	NETHERLANDS	$17.5K	5	2.6%
8	IRELAND	$12.2K	5	1.8%
9	CANADA	$7.8K	20	1.2%
10	GUYANA	$2.7K	1	0.4%

Showing top 10 of 25 origin countries

UNITED ARAB EMIRATES is the largest supplier of pantoprazole to India, accounting for 26.8% of total import value. The top 5 origin countries — UNITED ARAB EMIRATES, UNITED STATES, GERMANY, BRAZIL, FRANCE — together supply 90.3% of India's pantoprazole imports. Click any country to see detailed supplier and buyer data for that import corridor.

Pantoprazole — Export Intelligence Video

Visual overview of India's pantoprazole import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's pantoprazole pharmaceutical import and export market — $1.3B in total trade, 744 verified manufacturers, and 154 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Pantoprazole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, pantoprazole has been widely accepted in the pharmaceutical market. The FDA's Orange Book lists numerous approved Abbreviated New Drug Applications (ANDAs) for pantoprazole, indicating a robust generic market presence. The first generic versions were approved in 2007, following the expiration of the original patent held by Wyeth Pharmaceuticals. This early approval led to significant litigation, culminating in a 2013 settlement where Teva Pharmaceuticals agreed to pay $2.15 billion in damages for patent infringement. The substantial number of ANDA approvals underscores the competitive landscape, aligning with the presence of 744 active Indian exporters supplying pantoprazole to the U.S. market.

2EU & UK Regulatory Framework

In the European Union, pantoprazole has been authorized under various brand names, including Pantozol Control, Controloc Control, and Somac Control. These authorizations were granted in June 2009 for the short-term treatment of reflux symptoms in adults. However, some marketing authorizations, such as for Pantecta Control, were withdrawn in September 2016 at the request of the marketing authorization holder, Takeda GmbH, due to commercial reasons. Despite these withdrawals, other formulations like Pantozol Control remain authorized and available in several EU countries. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with the EMA's decisions, ensuring consistent regulatory standards across the region.

3WHO Essential Medicines & Global Standards

Pantoprazole is included in the World Health Organization's (WHO) Model List of Essential Medicines, reflecting its importance in treating acid-related disorders. The 23rd list, published in July 2023, continues to feature pantoprazole, emphasizing its critical role in global health. This inclusion facilitates its adoption in national essential medicines lists, promoting broader access. Regarding pharmacopoeial standards, pantoprazole is recognized in major compendia, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality standards across different markets.

4India Regulatory Classification

In India, pantoprazole is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for pantoprazole, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products; however, pantoprazole is generally exempt from such requirements, facilitating its export process.

5Patent & Exclusivity Status

The primary patent for pantoprazole expired in 2010, leading to the introduction of generic versions. Subsequent patents, such as US7544370, which covers pantoprazole multiparticulate formulations, are set to expire in June 2026. This impending expiration is expected to further intensify generic competition in the market.

6Recent Industry Developments

In March 2025, the NPPA conducted a review of PPI pricing, including pantoprazole, to assess market dynamics and ensure fair pricing practices. In June 2025, the FDA approved a new generic formulation of pantoprazole, enhancing market competition and potentially reducing costs for consumers. In September 2025, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of pantoprazole, which underscores its continued relevance in global healthcare. In December 2025, the EMA issued a safety communication regarding PPIs, including pantoprazole, highlighting the importance of monitoring for potential long-term adverse effects. In February 2026, the CDSCO implemented stricter quality control measures for exported pharmaceuticals, impacting pantoprazole manufacturers and exporters by necessitating enhanced compliance protocols.

These developments reflect the dynamic regulatory landscape surrounding pantoprazole, emphasizing the need for continuous monitoring and compliance to navigate the evolving global pharmaceutical market.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Pantoprazole

Retail & reference prices across 9 markets vs. India FOB export price of $3.77/unit

Global Price Benchmark for Pantoprazole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.50	USD	According to the FDA's Orange Book, Pantoprazole is available as a generic medication, contributing to its affordability.
United Kingdom	$0.40	GBP	The NHS Drug Tariff lists Pantoprazole as a reimbursable item, ensuring standardized pricing across the UK.
Germany	$0.38	EUR	The Federal Joint Committee (G-BA) includes Pantoprazole in its list of reimbursable medications, reflecting its essential status in treatment protocols.
Australia

Supply Chain Risk Assessment — Pantoprazole

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). Approximately 60–70% of these essential components are imported from China, underscoring a significant dependency. This reliance poses a risk, as any disruption in the supply chain from China can directly impact the production of Pantoprazole in India.

Recent geopolitical tensions have exacerbated this vulnerability. In March 2026, the closure of the Strait of Hormuz due to military conflicts led to significant disruptions in global shipping routes, affecting the transportation of raw materials and APIs. Such events highlight the fragility of the supply chain and the potential for production delays or shortages.

2Supplier Concentration & Single-Source Risk

The export market for Pantoprazole from India is highly concentrated. The top five exporters—Mylan Laboratories Limited, Aurobindo Pharma Ltd, Eugia Pharma Specialities Limited, Sun Pharmaceutical Industries Limited, and Torrent Pharmaceuticals Ltd—account for 87.9% of total exports. Notably, Mylan Laboratories Limited alone holds a 69.2% share, exporting $926.3 million USD worth of Pantoprazole. This concentration presents a single-source risk; any operational or regulatory issues faced by these key players could significantly disrupt the supply chain.

Access Complete Pantoprazole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 11,610 transactions across 154 markets.

Request Demo View Pricing

Frequently Asked Questions — Pantoprazole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top pantoprazole exporters from India?

The leading pantoprazole exporters from India are MYLAN LABORATORIES LIMITED, AUROBINDO PHARMA LTD, EUGIA PHARMA SPECIALITIES LIMITED, and 12 others. MYLAN LABORATORIES LIMITED leads with 69.2% market share ($926.3M). The top 5 suppliers together control 87.9% of total export value.

What is the total export value of pantoprazole from India?

The total export value of pantoprazole from India is $1.3B, recorded across 11,610 shipments from 744 active exporters to 154 countries. The average shipment value is $115.3K.

Which countries import pantoprazole from India?

India exports pantoprazole to 154 countries. The top importing countries are UNITED STATES (68.3%), MALTA (12.6%), CANADA (6.3%), BELGIUM (1.3%), TANZANIA (1.2%), which together account for 89.8% of total export value.

What is the HS code for pantoprazole exports from India?

The primary HS code for pantoprazole exports from India is 30049039. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Pantoprazole

Pantoprazole

Top Pantoprazole Exporters from India

Top Countries Importing Pantoprazole from India

Who Supplies Pantoprazole to India?

Quick Facts

Related Gastrointestinal

Related Analysis

Need Details?

Pantoprazole — Export Intelligence Video

Regulatory Landscape — Pantoprazole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Pantoprazole

Supply Chain Risk Assessment — Pantoprazole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Pantoprazole Trade Intelligence

Frequently Asked Questions — Pantoprazole Exports from India

Who are the top pantoprazole exporters from India?

What is the total export value of pantoprazole from India?

Which countries import pantoprazole from India?

What is the HS code for pantoprazole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of pantoprazole exports from India?

Which ports handle pantoprazole exports from India?

Why is India a leading exporter of pantoprazole?

What certifications do Indian pantoprazole exporters need?

How many buyers import pantoprazole from India?

What is the market share of the top pantoprazole exporter from India?

Analysis Methodology